Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 1;16(12):2932-2937.
doi: 10.1080/21645515.2020.1826249. Epub 2020 Nov 11.

Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development

Kranti Suresh Vora  1   2 , Aarthi Sundararajan  1 , Shahin Saiyed  3 , Kuldeep Dhama  4 , Senthilkumar Natesan  1   3
Affiliations
Review

Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development

Kranti Suresh Vora et al. Hum Vaccin Immunother. .

Abstract

The COVID-19 pandemic has imposed unprecedented health and socioeconomic challenges on public health, disrupting it on a global scale. Given that women and children are widely considered the most vulnerable in the times of emergency, whether in war or during a pandemic, the current pandemic has also severely disrupted access to reproductive and child health services. Despite this, data on the effect of the pandemic on pregnant women and newborns remain scarce, and gender-disaggregated indicators of mortality and morbidity are not available. In this context, we suggest the implementation of a gendered approach to ensure the specific needs of women and their newborns are considered during the development of COVID-19 vaccines. Taking into account gender-based biological differences, the inclusion of pregnant and lactating mothers in clinical trials for the development of COVID-19 vaccines is of vital importance.

Keywords: COVID-19; gendered approach; vaccine; vaccine development; women and child health.

PubMed Disclaimer

References

    1. Di Daniele M, Asma K, Gabriele S, Giuseppe R, Danilo B, Marco L, Jacopo V, Luigi N, Giovanni S, Vincenzo B, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID 1-19) during pregnancy: a systematic review and meta-analysis. Am J Obs Gynecol MFM. 2020;PII:S2589-9333(20)30037–9. doi:10.1016/j.ajogmf.2020.100107. - DOI - PubMed
    1. Miller ES, Grobman WA, Sakowicz A, Rosati J, Peaceman AM.. Clinical implications of universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in pregnancy. Obstet Gynecol. 2020. May 19;136(2):232–34. Epub ahead of print. PMID: 32433449. doi:10.1097/AOG.0000000000003983. - DOI - PubMed
    1. Dehan L, Lin L, Xin W, Dandan Z, Jiazheng W, Lian Y, Chuansheng Z. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. Am J Roentgenol. 2020;215:1–6. doi:10.2214/AJR.20.23072. - DOI - PubMed
    1. Chen L, Li Q, Zheng D, Jiang H, Wei Y, Zou L, Feng L, Xiong G, Sun G, Wang H, et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N Engl J Med. 2020. Apr 17;382(25):e100. Published Online First. doi:10.1056/NEJMc2009226. - DOI - PMC - PubMed
    1. David S. An analysis of 38 pregnant women with 2 COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020. Forthcoming [published online ahead of print, 2020 March 17]. doi:10.5858/arpa.2020-0901-SA. - DOI - PubMed

Substances